AmpliPhi Biosciences Corporation (NYSE: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE